Chief Investment Officer of my PA. Buy and hold ๐บ๐ธ cannabis MSOs and multifamily RE ๐ข. No investment advice here. Tweets are only my opinions.
DEA Schedule 3 ruling won't be a "sell the news" event imo.. there's too much money on the sidelines waiting for that signal to buy.
$CURLF $GTBIF $VRNOF $TCNNF $CRLBF $TSND $AAWH $AYRWF $MSOS
@SenSchumer
@FordhamNYC
Cool glasses Chuck.. now can you please put SAFER banking up for a vote so we can protect the 400k+ legal cannabis sector workers?
Biden mentioning cannabis rescheduling during SOTU.. after the public release of the full HHS recommendation.. tells you:
1) White House approves Schedule 3
2) DEA will accept this
Coordinated effort.
$MSOS
Dear
@DEAHQ
,
DEA received HHS recommendation 8 months ago.
The VP, Heads of HHS & FDA, Congress members & your constituents.. are publicly questioning DEA's delay.
DEA should provide its ruling or give transparency into the process.
Timely reminder on Rescheduling:
1) vastly more important than SAFER (bye 280E)
2) doesn't require congressional action
3) already in process
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $MSOS
Respectfully..
Cannabis investors & advocates are a small community as it is. Let's appreciate everyone who contributes.. those that post quantitative data.. make memes.. host spaces.. call out politicians.. read charts, etc..
Same team.
$MSOS
Most cannabis investors on Twitter know significantly more about the sector than 99% of global institutional capital.. for now..
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $MSOS
Napkin math.
MSO's trade at 8x 2023 EBITDA while offering 25% profit growth.
S&P trades at 12.8x for 8% growth.
Giving MSO's the same multiple/growth ratio suggests MSO's *should* trade at 40x.
Easy to see the 5x rerating opportunity.
$CURLF $GTBIF $TCNNF $CRLBF $VRNOF
@cannabisinves11
Revised comp sheet fixing '21 ev/ebitda valuation for $CRLBF and $VRNOF that were incorrectly showing '20 valuation figures for those 2 cells. All of the other 198 valuation figures were and remain correct. ๐ ๐๐
@cannabisinves11
Whether the DEA proposed ruling is released next week or in a few months, very little chance they go against the HHS S3 recommendation (especially as news of it becomes more mainstream).
This is a coordinated effort.
$MSOS
While the rescheduling process is still with DEA.. the American Medical Association has now published 2 separate reports in April saying cannabis legalization doesn't lead to increased youth usage.
Coincidence? $MSOS
SAM has pivoted their efforts to stock manipulation & trolling investors..
instead of engaging govt appointees involved in Rescheduling..
shows they accept Schedule 3 will be confirmed.
This is bullish. $MSOS
Jefferies published a 100+ page thesis refresher on US cannabis.
Seems the largest bank to cover the sector is confident in the potential for more institutional interest. $MSOS
My IT dept is working on a clean recording of yesterdayโs Spaces with $CURLF Chairman
@Boris_Jordan
.
*By โIT deptโ I really mean me so stay tuned ๐.
White House pushing cannabis reform & mentioning rescheduling again today.. while knowing HHS recommended Schedule 3 & Kamala called on DEA to "get to it quickly".
It all seems so scripted. $MSOS
$MSOS was $15 on hopes of only a banking bill.
At $8 today and we have strong prospects for Rescheduling, some big states flipping AU, normalized taxes, & increased profits.. on top of much stronger biz models.
$CURLF $GTBIF $VRNOF $CRLBF $TCNNF $TSND $MSOS
Same-sex marriage was legalized by SCOTUS in 2015.. when it was legal in 37 states & with 58% popular support.
Compare that with Cannabis.. legal in 38 states & with nearly 70% popular support today.
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $MSOS
Imminent DEA proposed ruling hugely increases the chances that Schedule 3 will be finalized before the election.
This has been coordinated & orchestrated since POTUS ordered the rescheduling review. $MSOS
Daily swings in stocks irrelevant to LT investors.
Both Dems and GOP are jockeying for control of cannabis reform.
Mace's bill is a big de-risking catalyst.
Top MSO's are cashed up and generating profits.
It's "when" not "if".
$CURLF $GTBIF $TCNNF $CRLBF $VRNOF $MSOS
Don't say it much but wanted to express my gratitude for this community. Too many accounts to name that are all adding value in complimentary ways. Thankful for those that just passively follow/read/listen too.
$MSOS
We're at the stage where Schedule 3 is a 90% certainty.. while maybe only 5% of retail investors and 1% of institutional investors even know about the sector.
We'll need more media coverage for the stocks to work much higher. $MSOS
I value this $CURLF refinancing at ~7% accretive to shareholders.
Back of envelope math.
$20m potential interest savings at 25x multiple = $500m
Bigger takeaway is that credit markets are very open for ๐บ๐ธ cannabis even without SAFE.
$MSOS
Super proud of the
@Curaleaf
teamโ todayโs debt offering raises $425M at 8% interest, reducing cost of funding by 700 basis points from Jan. 2020! Major milestone for us AND the industry- largest debt offering ever for a US-based cannabis Co. $CURA $CURLF
Germany legalizing cannabis is an important milestone.
It's the 3rd largest country in the world by GDP & most populous EU member (85m people).
$CURLF $GTBIF $VRNOF $TCNNF $CRLBF $TSND $MSOS
Can't overstate how significant Schedule 3 would be for Cannabis.
e.g. Curaleaf expects $150m+ of tax savings (cash flow).. which with 280E today, would have taken a TRIPLING of sales to produce (per
@Boris_Jordan
).
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $MSOS
Strongly agree with others' take on this..
Recently increased rhetoric from the prohibitionists = further confirmation that Rescheduling & SAFER is closer than ever. $MSOS
Biggest surprise from today is the coordinated videos/messages from POTUS, the VP & the DOJ on Rescheduling (as OMB approval & NPRM was expected).
Shows it's a priority & completely orchestrated. $MSOS
Name another potential $100+ billion market where stocks have been deserted.. with multiple significant catalysts on the horizon?
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $MSOS
Released by popular demand..
My chat with Curaleaf Executive Chairman
@Boris_Jordan
.
I know the Twitter community appreciates his engagement.
Also ๐ to
@march2millions
for helping edit this.
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $MSOS
A year from now we will likely see:
*cannabis on $30b run rate
*Top MSO's strongly growing EBITDA/FCF ($ > %)
*NJ launched
*optimism for NY 2023
*closer to rec in FL, PA, & OH
*cost of debt improved
*SAFE enacted
*path to eventual uplisting
Forest > Trees.
Me this weekend trying not to "bore" friends/family by talking.. MSO's, Rescheduling, SAFE, Senate markups, AG memos, 280E, uplisting, yada yada yada..
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $MSOS
Just listened to
@bcobblaw
on his 18th podcast this month.
If SAFE passes in '21, much respect for his work and dedication.
If not, much respect for his continuing work and dedication.
Big props either way.
$CURLF $GTBIF $TCNNF $CRLBF $VRNOF $TRSSF $AYRWF $MSOS
Potential catalysts on deck for ๐บ๐ธ cannabis:
Schedule 3
no 280E
SAFE Banking
Garland memo
FL/OH/PA legalization
Better/leaner biz models
Uplisting
..all while $MSOS still -50% from Dec 2022 SAFE peak.
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND
Huge generational gap between who voted YES (orange) vs. NO (purple) on cannabis in Ohio's election.
Rescheduling or legalization inevitable.
(source: NBC News)
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $MSOS
If Schedule 3's confirmed, stocks could double & still be wildly undervalued.
Makes sense that larger investors would just wait & pay up for certainty.
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $MSOS
Still think this Rescheduling review is coordinated & scripted.. so would expect to hear *something* during what the WH deemed to be "Second Chance" month. $MSOS
The fact that DEA didn't sign the proposed rule doesn't matter:
1) AG Garland (the DEA's "boss") signed it
2) Biden (DOJ's "boss" ) strongly promoted Schedule 3
3) OLC opinion looks strong
Schedule 3 highly likely. $MSOS
Guessing
@JasonGWild
doesn't need to know exactly when SAFE will pass.
Maybe he only checks on his portfolio a couple times daily.
He might even have a time horizon longer than a month.
Be more like JW.
$TRSSF $MSOS
More
@JasonGWild
, with the most beastly insider buying we can recall. Another ~$188k of reported common shares purchases today and $1.746M reported yesterday (21 Tx between both days). By our rough math, Jason has purchased ~$3.7million in $TRSSF stock since November 19th.
Told an institutional investor that's buying ๐บ๐ธ cannabis that they must be a bit lonely being one of the first.
Their reply?
"That's when we often generate our best returns".
Well said.
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TRSSF $MSOS
Which MSOs charts should you be looking at?ย
Needham shows top MSO's revenue up and to the right.ย
Stock prices are the other way.ย
This is what I call a huge opportunity.
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $MSOS
Bad news: institutional capital doesn't own US cannabis.
Good news: institutional capital doesn't own US cannabis yet.
$CURLF $GTBIF $VRNOF $TCNNF $CRLBF $TSND $AAWH $AYRWF $MSOS
We've cleared the highest hurdle with HHS Schedule 3 recommendation..
the DEA seems boxed in & almost has to agree..
and comment period won't change HHS & DEA's decision.
Schedule 3 is just a matter of time. $MSOS
We have a detailed 250+ page HHS recommendation (historic).. press saying DEA ruling soon.. & politicians getting louder (frontrunning decision?).
Schedule 3 is still the most likely outcome..
don't let stock prices or sentiment convince you otherwise. $MSOS
If/when Schedule 3 confirmed, the largest MSO's would each see $100m+ of annual tax savings (Curaleaf $150m+).
20x multiple on $100m = $2 billion of value ($3b for Curaleaf).. on current mkt caps of $1-3.5 billion.
$CURLF $GTBIF $VRNOF $CRLBF $TCNNF $TSND $MSOS
Significance of Schedule 3 rec still underrated by the market.
Cannabis sector has made investors skeptical (understandably).. but this is way more meaningful than "SAFE in NDAA" chatter (when $MSOS saw $14).
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND
If Ohio approves cannabis by a wide margin (60%+).. that would be just as (if not more) important than SAFE to the bull thesis imho.
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $MSOS
New AP article says:
1) DOJ signing Schedule 3 NPRM been planned since at least March
2) some DEA people think it politically motivated
3) implies Biden wants it done before election
This is bullish. $MSOS
GTI and Verano showing real Free Cash Flow (after 280E) while competing with a larger untaxed illicit market..
is like running a marathon with 20 lb ankle weights.
How fast can they run in a Schedule 3 world?
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $MSOS
VP just gave this update on cannabis rescheduling (loose quote):
โI cannot emphasize enough that we want them to get to this as quickly as possible.. Iโm sure the DEA is working quickly and we look forward to hearing their workโ.
The message is clear.
$MSOS
UPLISTING is the real IPO for cannabis co's.
Until then, MSO's are semi-private co's trading in an inefficient market.
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $MSOS
You know weโre super close to cannabis reform when a few senators mention a stale/irrelevant UN treaty, ask DEA not to act on โpoliticalโ reasons & SAM does a victory lap. $MSOS
SAM saying Schedule 3 soon.
DEA said comment period likely.
DEA supply chain conference tomorrow.
Itโs still โSecond Chanceโ month.
Timing is anyoneโs guess though.
$MSOS
Look at the VPโs words, tone & body language (mentions marijuana safer than heroin which is Schedule 2 twice)..
Itโs clear the WH is in charge here & DEA almost has to accept Schedule 3.
$MSOS
Germany's legalization of cannabis is important bc:
1. Pressures ๐บ๐ธ to at least do something
2. Shows how quickly positive reform can happen
3. Validates $CURLF EMMAC acqn
4. Other MSO's may start evaluating a global strategy
Btw ๐ฉ๐ช ranked
#4
in global GDP.
$MSOS
MSO stocks would be at least double today's prices imo.. if they had US big board listings & increased trading volume.
Curaleaf would conservatively be $10-15.
$CURLF $MSOS
April likely to be a pivotal month for the cannabis sector:
1) FL Supreme Court ruling on ballot question (April 1)
2) DEA rescheduling ruling?
3) SAFER progress?
4) More comments from POTUS or the VP?
$MSOS
MSO's should spend huge $ on the FL ballot campaign ($100m+).
Ensuring a "yes" on legalization not only opens up the most important market to MSO's to date.. but also sends strong signal to DC & other red states. $MSOS
Will say it again: this whole Rescheduling process is 100% controlled by the White House.
If they want it finalized before the election (or pre-voting), it will be done. $MSOS
Realize the sector is starved for a fed reform catalyst but.. SAFER isn't a thesis (allowing credit cards would be nice though).
The thesis is: Schedule 3 + new states + improving biz models + uplisting.
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $MSOS
Investors only see outsized returns when buying BEFORE significant catalysts.
Key is having confidence in the thesis & catalysts before they're universally accepted.
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $MSOS
Desantis' opinion on FL ballot is irrelevant.
FL already one of largest markets ($2b+) with just med.
Citizens want legal cannabis & will vote accordingly. $MSOS
All these fundamental catalysts are still on deck.
$MSOS +20% move in a week is an anthill compared to the mountain of Growth + Multiple Expansion that we'll see.
$CURLF $GTBIF $TCNNF $CRLBF $VRNOF $TRSSF $AYRWF $MSOS
A year from now we will likely see:
*cannabis on $30b run rate
*Top MSO's strongly growing EBITDA/FCF ($ > %)
*NJ launched
*optimism for NY 2023
*closer to rec in FL, PA, & OH
*cost of debt improved
*SAFE enacted
*path to eventual uplisting
Forest > Trees.
Historic day as cannabis rescheduling was officially published in the Federal Register today.
This whole process is unprecedented with it being planned & coordinated at the highest levels of the US executive branch. $MSOS
Imho.. cannabis stocks likely to be uncorrelated to the broader equity markets in next 12+ months.. just like it was for past 2+ yrs.
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $MSOS
The DEA has to pound their chest & appear to be independent.
Very likely "their" decision has already been made.. and made for them by the White House.
Schedule 3.
$MSOS
LinkedIn post says rescheduling update may be imminent.. $MSOS at $10.
First time cannabis reform is mentioned in SOTU by any President.. $MSOS at $8.
Welcome to cannabis investing.
Being a LT bull on the US cannabis sector has meant believing:
1) biz's would eventually evolve into a "legitimate" sector like others
2) inevitability of state/fed catalysts
Still much work to do.. but today is a huge positive step in the right direction.
$MSOS at same price as 16 mo's ago when WH initiated the rescheduling review.. despite a 250 page HHS recommendation that strongly supports Schedule 3.
Definitely surprising but also not really surprising, right?
$CURLF $GTBIF $VRNOF $TCNNF $CRLBF $TSND $MSOS
Ascend will file for tax refunds & won't pay 280E going forward (like Trulieve).
There's strength in numbers & more MSO's doing this raises the odds of success in challenging this unfair/unconstitutional tax rule imho.
$CURLF $GTBIF $TCNNF $VRNOF $CRLBF $TSND $AAWH $MSOS
You can either be frustrated by $CGC rocketing while $MSOS yawns..
or confident as it's a blueprint for where MSO's go upon tangible catalysts.
I'm bit of both.. but more the latter.
The DEA Supply Chain conference is at the Four Points Sheraton in Little Rock next week.
Lobby bar would be a good place for some due diligence... $MSOS